{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:42:06Z","timestamp":1790836926448,"version":"4.1.0"},"publisher-location":"Boston, MA","reference-count":20,"publisher":"Springer US","isbn-type":[{"value":"9781461380382","type":"print"},{"value":"9781461304074","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-1-4613-0407-4_15","type":"book-chapter","created":{"date-parts":[[2011,9,12]],"date-time":"2011-09-12T05:33:03Z","timestamp":1315805583000},"page":"103-109","source":"Crossref","is-referenced-by-count":3,"title":["CANNABINOIDS AND IMMUNITY TO Legionella pneumophila INFECTION"],"prefix":"10.1007","author":[{"given":"Thomas W.","family":"Klein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"15_CR1","first-page":"303","volume-title":"Immunotoxicology and Immunopharmacology","author":"H Friedman","year":"1994","unstructured":"Friedman, H., Shivers, S., and Klein, T.W., Drugs of abuse and the immune system. In: Dean, J.H., Luster, M. I., Munson, A.E., and Kimber, I. (eds.), Immunotoxicology and Immunopharmacology, Second Edition, pp. 303\u2013322, Raven Press, New York, 1994.","edition":"2"},{"key":"15_CR2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0026-895X(25)09130-8","volume":"42","author":"NE Kaminski","year":"1992","unstructured":"Kaminski, N.E., Abood, M.E., Kessler, F.K., Martin, B.R., and Schatz. A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation. Mol. Pharm. 42: 736\u2013742, 1992.","journal-title":"Mol. Pharm"},{"key":"15_CR3","series-title":"J. Pharmacol. Exp. Ther","first-page":"276","volume-title":"Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation","author":"Y Daaka","year":"1996","unstructured":"Daaka, Y., Friedman, H., and Klein, T.W. Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation. J. Pharmacol. Exp. Ther. 276: 1996 (in press)."},{"key":"15_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0022-3565(25)39360-2","volume":"267","author":"TW Klein","year":"1993","unstructured":"Klein, T.W., Newton, C., Widen, R., and Friedman, H. \u03949-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. 267: 635\u2013640, 1993.","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"15_CR5","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/IAI.62.9.4015-4020.1994","volume":"62","author":"CA Newton","year":"1994","unstructured":"Newton, C.A., Klein, T.W., and Friedman, H. Secondary immunity to Legionella pneumophila and Thl activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62: 4015\u20134020, 1994.","journal-title":"Infect. Immun"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/0006-2952(94)90163-5","volume":"48","author":"S Burstein","year":"1994","unstructured":"Burstein, S., Budrow, J., Debatis, M., Hunter, S.A., and Subramanian, A. Phopholipase participation in cannabinoid-induced release of free arachidonic acid. Biochem. Pharmacol. 48: 1253\u20131264, 1994.","journal-title":"Biochem. Pharmacol"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0167-5699(93)90208-3","volume":"14","author":"M Clerici","year":"1993","unstructured":"Clerici, M. and Shearer, G.M. A Thl to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14: 107\u2013111, 1993.","journal-title":"Immunol. Today"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/346561a0","volume":"346","author":"LA Matsuda","year":"1990","unstructured":"Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., and Bonner, T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561\u2013546, 1990.","journal-title":"Nature"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/0024-3205(84)90278-9","volume":"35","author":"AC Howlett","year":"1984","unstructured":"Howlett, A.C. Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds. Life Sci. 35: 1803\u20131810, 1984.","journal-title":"Life Sci"},{"key":"15_CR10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0026-895X(25)10219-8","volume":"29","author":"AC Howlett","year":"1986","unstructured":"Howlett, A.C., Qualy, J.M., and Khachatrian, L.L. Involvement of G, in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharm. 29: 307\u2013313, 1986.","journal-title":"Mol. Pharm"},{"key":"15_CR11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0022-3565(25)38122-X","volume":"265","author":"DR Compton","year":"1993","unstructured":"Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R., and Martin, B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265: 218\u2013226, 1993.","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"15_CR12","first-page":"21","volume":"23","author":"KJ Tracey","year":"1990","unstructured":"Tracey, K.J. and Lowry, S.F. The role of cytokine mediators in septic shock. Adv. Surg. 23: 21\u201356, 1990.","journal-title":"Adv. Surg"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/365061a0","volume":"365","author":"S Munro","year":"1993","unstructured":"Munro, S. Thomas, K.L., and Abu-Shaar, M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61\u201365, 1993.","journal-title":"Nature"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1074\/jbc.270.8.3726","volume":"270","author":"D Shire","year":"1995","unstructured":"Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., Caput, D., and Ferrara, P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270: 3726\u20133731, 1995.","journal-title":"J. Biol. Chem"},{"key":"15_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S Galieque","year":"1995","unstructured":"Galieque, S., Mary, S., Marchand, J., Dussossoy, D, Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G., and Casellas, P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232: 54\u201361, 1995.","journal-title":"Eur. J. Biochem"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/0006-2952(94)90588-6","volume":"48","author":"N Kaminski","year":"1994","unstructured":"Kaminski, N., Koh, W.S., Yang, K.H., Lee, M., and Kessler, F.K. Suppression of the humoral immune response by cannabinoids is partially mediated through inhibition of adenylate cyclase by a pertussis toxin-sensitive G-protein coupled mechanism. Biochem. Pharm. 48: 1899\u20131908, 1994.","journal-title":"Biochem. Pharm"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0167-5699(88)91220-0","volume":"9","author":"GM Kammer","year":"1988","unstructured":"Kammer, G.M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9: 222\u2013229, 1988.","journal-title":"Immunol. Today"},{"key":"15_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4049\/jimmunol.146.1.108","volume":"146","author":"M Betz","year":"1991","unstructured":"Betz, M. and Fox, B.S. Prostaglandin E2 inhibits production of Thl lymphokines but not of Th2 lymphokines. J. Immunol. 146: 108\u2013113, 1991.","journal-title":"J. Immunol"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0008-8749(95)80039-L","volume":"160","author":"CW Parker","year":"1995","unstructured":"Parker, C.W., Huber, M.G., and Godt, S.M. Modulation of IL4 production in murine spleen cells by prostaglandins. Cell. Immunol. 160: 278\u2013285, 1995.","journal-title":"Cell. Immunol"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/0024-3205(93)90014-T","volume":"53","author":"WB Starr","year":"1993","unstructured":"Starr, W.B., Van Oosterhout, A.J.M., and Nijkamp, F P. Minireview:Pharmacologic modulation of Thland Th2-associated lymphokine production. Life Sci. 53: 1921\u20131934, 1993.","journal-title":"Life Sci"}],"container-title":["Advances in Experimental Medicine and Biology","AIDS, Drugs of Abuse, and the Neuroimmune Axis"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4613-0407-4_15.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:46:31Z","timestamp":1741617991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4613-0407-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9781461380382","9781461304074"],"references-count":20,"URL":"https:\/\/doi.org\/10.1007\/978-1-4613-0407-4_15","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1996]]}}}